| Preliminary results from studies examining bispecific antibodies for treatment of relapsed b-cell lymphomas. |
Home / Resource Library / Preliminary results from phase I studies of CD20 x CD3 bispecific antibodies in R/R B-cell non-Hodgkin lymphoma